VP6: A Candidate Rotavirus Vaccine

scientific article published on September 1, 2010

VP6: A Candidate Rotavirus Vaccine is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1086/653556
P953full work available at URLhttps://academic.oup.com/jid/article-pdf/202/Supplement_1/S101/18063395/202-Supplement_1-S101.pdf
https://academic.oup.com/jid/article/202/Supplement_1/S101/829498/VP6-A-Candidate-Rotavirus-Vaccine
P698PubMed publication ID20684688

P2093author name stringMonica M. McNeal
Richard L. Ward
P407language of work or nameEnglishQ1860
P921main subjectvaccineQ134808
P304page(s)S101-7
P577publication date2010-09-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleVP6: A candidate rotavirus vaccine
VP6: A Candidate Rotavirus Vaccine
P478volume202 Suppl

Reverse relations

cites work (P2860)
Q41326217Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate
Q36210208Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.
Q40218330Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
Q52648250Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
Q37473348Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model
Q42233820Immunogenicity and protective efficacy of yeast extracts containing rotavirus-like particles: a potential veterinary vaccine.
Q34510430Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice
Q34711833Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea
Q40527380Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes.
Q38743049Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles
Q58759991Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model
Q37135255Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine
Q40243520Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
Q33812653Subviral particle as vaccine and vaccine platform
Q33720570Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein
Q41350061Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Q57490842The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination
Q39232838The rotavirus vaccine development pipeline.
Q37691015Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.
Q34907018Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice
Q39063072Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine

Search more.